What is PharmaSecure?
PharmaSecure specializes in providing robust supply chain traceability solutions tailored for the pharmaceutical industry. Their comprehensive service offerings encompass serialization, track and trace, product authentication, and consumer engagement, all underpinned by patented technology. For over 15 years, PharmaSecure has been instrumental in securing billions of pharmaceutical products and integrating its advanced solutions across numerous production lines. The company's expertise is relied upon by major pharmaceutical corporations worldwide, who depend on PharmaSecure for stringent regulatory adherence and optimized operational efficiency, thereby safeguarding product integrity and patient safety.
How much funding has PharmaSecure raised?
PharmaSecure has raised a total of $3.9M across 1 funding round:
Unspecified
$3.9M
Unspecified (2011): $3.9M with participation from TEEC Angel Fund, HealthTech Capital, Innovation Endeavors, and Gray Ghost Ventures
Key Investors in PharmaSecure
TEEC Angel Fund
TSVC, formerly TEEC Angel Fund, is a venture capital firm focused on investment opportunities. The firm is known for its involvement in legal actions concerning brand misrepresentation, aiming to protect its reputation and investor trust while seeking reliable investment partnerships.
HealthTech Capital
HealthTech Capital is a private investment organization dedicated to healthtech and digital health startups, providing funding and mentorship since 2010. It connects investors with early-stage healthtech ventures, having facilitated over $1 billion in follow-on capital.
Innovation Endeavors
Innovation Endeavors is an early-stage venture capital firm that invests in transformative technologies and emergent ecosystems, focusing on data, computation, and advanced engineering to reshape various industries.
What's next for PharmaSecure?
With its substantial enterprise-level backing and a recent strategic investment, PharmaSecure is poised for significant growth and innovation. The company's focus on critical areas such as combating pharmaceutical counterfeiting and ensuring compliance with evolving global regulations positions it for continued leadership. Future developments are likely to involve further technological advancements in its traceability platforms, expanded market penetration, and strategic partnerships to enhance its global reach. This sustained capital commitment signals confidence in PharmaSecure's business model and its capacity to address the persistent challenges within pharmaceutical supply chain integrity.
See full PharmaSecure company page
